Regenerative Medicine and Stem Cell Therapy for Cardiovascular Diseases: From Bench to Bedside
Submission Deadline: 30 Sep 2026
Guest Editor
Special Issue Information
Dear Colleagues,
Regenerative therapy has recently emerged for treating cardiovascular diseases, and numerous preclinical and clinical studies using various types of stem cells are being conducted. For example, induced pluripotent stem (iPS) cells represent an unlimited source of a variety of cells because of their great potential for differentiation and are therefore one of the most promising sources of cells for cardiovascular regenerative therapy.
This Special Issue invites both original articles and reviews, providing the readers with a comprehensive elucidation about cardiovascular regenerative therapy, tissue engineering, stem cell therapy, and stem cell biology.
Prof. Tadahisa Sugiura
Guest Editor
Keywords
- cardiac regenerative medicine
- induced pluripotent stem cell
- stem cell biology
- stem cell therapy
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.